Ian Page

Ian Page discloses dealings in Dechra Pharmaceuticals PLC to RNS (LSE). The record holds 9 filings, for trades running from 2 March 2018 to 15 January 2024.

The open-market record is one-sided, with 4 purchases worth €5,838 and not one sale. The totals exclude 3 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants. In 2024 alone, the filings show 4 purchases and no sales.

On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 15 January 2024, reports an open-market purchase of €5,838 in Dechra Pharmaceuticals PLC. Most trades are made public on the day they happen. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.